NUVB
Nuvation Bio Inc
NYSE: NUVB · HEALTHCARE · BIOTECHNOLOGY
$4.34
-4.82% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
23.99x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$2 – $10
Volume
4.2M
Nuvation Bio Inc (NUVB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-7.0%
Last 4 quarters
Revenue YoY growth
+633.1%
Most recent quarter
EPS YoY growth
+5.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-11.9%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-26.2%
2026-03-02
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-0.11 | -22.2% | $5.91 | $4.36 | -26.2% |
| 2025-11-03 | $-0.16 | +5.9% | $5.22 | $4.83 | -7.5% |
| 2025-08-07 | $-0.17 | +0.0% | $2.35 | $2.30 | -2.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.09 | $-0.11 | -22.2% | $41.87M | +633.1% |
| 2025-09-30 | $-0.17 | $-0.16 | +5.9% | $13.12M | +1704.7% |
| 2025-06-30 | $-0.17 | $-0.17 | +0.0% | $4.83M | +236.8% |
| 2025-03-31 | $-0.12 | $-0.13 | -11.7% | $3.08M | +1068.2% |
| 2024-12-31 | $-0.12 | $-0.12 | +2.9% | $5.71M | +2063.3% |
| 2024-09-30 | $-0.13 | $-0.15 | -15.4% | $727000.00 | — |
| 2024-06-30 | $-0.06 | $-0.15 | -150.0% | $1.44M | — |
| 2024-03-31 | $-0.10 | $-0.07 | +30.0% | $264000.00 | — |
| 2023-12-31 | $-0.10 | $-0.06 | +40.0% | $264000.00 | — |
| 2023-09-30 | $-0.11 | $-0.09 | +18.2% | — | — |
| 2023-06-30 | $-0.11 | $-0.09 | +18.2% | — | — |
Frequently asked questions
Has Nuvation Bio Inc beaten earnings estimates?
Nuvation Bio Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -7.0% over the last 4 quarters.
How does NUVB stock react to earnings?
NUVB stock has moved an average of -11.9% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Nuvation Bio Inc's revenue growth rate?
Nuvation Bio Inc reported year-over-year revenue growth of +633.1% in its most recent quarter, with EPS growing +5.6% year-over-year.